Recurrence Patterns of Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Otolaryngol Head Neck Surg

Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA.

Published: October 2024

AI Article Synopsis

Article Abstract

Objective: The objective of this study was to describe risk factors and recurrence patterns that can guide the creation of evidence-based surveillance guidelines for advanced cutaneous squamous cell carcinoma of the head and neck.

Study Design: This was a single-institution retrospective case series.

Setting: High-volume academic head and neck surgical oncology practice.

Methods: Patients who underwent surgery for cutaneous squamous cell carcinoma of the head and neck staged Brigham and Women's Hospital T2b and T3 from 2003 to 2023 were reviewed. Patient demographics, clinicopathologic history, cancer data, treatment, and outcomes were abstracted. Disease-free survival and risk factors for recurrence were described.

Results: A total of 183 patients were included. Fifty-six (30.6%) experienced recurrence. This included local recurrence in 21 (11.5%), regional in 21 (13.3%), and distant in 11 (6%). The majority of regional and distant recurrences occurred within 1 year of surgery.

Conclusion: The majority of disease recurrence occurs in the first 1 to 2 years following surgical excision of advanced-stage cutaneous squamous cell carcinoma of the head and neck. Close surveillance and frequent imaging within those years are critical to catch subclinical and distant diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ohn.851DOI Listing

Publication Analysis

Top Keywords

cutaneous squamous
16
squamous cell
16
cell carcinoma
16
carcinoma head
16
head neck
16
recurrence patterns
8
advanced cutaneous
8
risk factors
8
factors recurrence
8
recurrence
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!